{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:07:18Z","timestamp":1787969238358,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100326"],"award-info":[{"award-number":["81100326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31402204"],"award-info":[{"award-number":["31402204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2012M520684"],"award-info":[{"award-number":["2012M520684"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015T80311"],"award-info":[{"award-number":["2015T80311"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["450060445322"],"award-info":[{"award-number":["450060445322"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["4305050102Q5"],"award-info":[{"award-number":["4305050102Q5"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["419080500374"],"award-info":[{"award-number":["419080500374"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["4305050102TZ"],"award-info":[{"award-number":["4305050102TZ"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Postdoctoral Science Foundation","award":["801130020428"],"award-info":[{"award-number":["801130020428"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.intimp.2016.06.028","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T15:45:17Z","timestamp":1467474317000},"page":"460-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21\/IL15 armed oncolytic adenovirus in TERT-positive tumor cells"],"prefix":"10.1016","volume":"38","author":[{"given":"Jun-feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.06.028_bb0005","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2174\/138920112800958887","article-title":"Synergistic interaction of telomerase-specific oncolytic virotherapy and chemotherapeutic agents for human cancer","volume":"13","author":"Fujiwara","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coi.2014.01.008","article-title":"Manipulating immune cells for adoptive immunotherapy of cancer","volume":"27","author":"Darcy","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.seminoncol.2007.09.002","article-title":"Adoptive cell transfer therapy","volume":"34","author":"Dudley","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrclinonc.2011.116","article-title":"Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know","volume":"8","author":"Rosenberg","year":"2011","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0025","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1172\/JCI32446","article-title":"Adoptive T, cell therapy for cancer in the clinic","volume":"117","author":"June","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.06.028_bb0030","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1182\/blood-2011-02-336321","article-title":"Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity","volume":"12","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.06.028_bb0035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.exphem.2011.06.005","article-title":"Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy","volume":"39","author":"Niam","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1182\/blood-2010-06-290858","article-title":"Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies","volume":"117","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.06.028_bb0045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s13277-013-1149-5","article-title":"Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model","volume":"2","author":"Yan","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0050","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1007\/s13277-015-3098-7","article-title":"Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity","volume":"6","author":"Yan","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0055","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1038\/sj.onc.1209044","article-title":"Oncolytic adenoviruses-selective retargeting to tumor cells","volume":"24","author":"Mathis","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2016.06.028_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-31-51","article-title":"Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo","volume":"31","author":"Zhu","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2016.06.028_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.cgt.7701105","article-title":"A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes","volume":"3","author":"Hu","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2016.06.028_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2015.07.005","article-title":"Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L","volume":"28","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cellimm.2014.03.020","article-title":"Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas","volume":"289","author":"Zhao","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0080","article-title":"Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.06.028_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2144\/01312bm04","article-title":"AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination","volume":"31","author":"Zeng","year":"2001","journal-title":"Biotechniques"},{"key":"10.1016\/j.intimp.2016.06.028_bb0090","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2016.06.028_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jgm.2687","article-title":"Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells","volume":"15","author":"Janssen","year":"2013","journal-title":"J Gene Med."},{"key":"10.1016\/j.intimp.2016.06.028_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.imbio.2014.02.009","article-title":"Adenovirus-mediated CCL20\/IL-15 gene transfer enhances antitumor immunity in mice","volume":"219","author":"Liu","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2016.06.028_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.gt.3300560","article-title":"Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene","volume":"5","author":"Finke","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2016.06.028_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3835(02)00089-7","article-title":"Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes","volume":"182","author":"Qiu","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2016.06.028_bb0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.cgt.7700666","article-title":"Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity","volume":"11","author":"Irving","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2016.06.028_bb0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700838","article-title":"Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment","volume":"12","author":"Uchino","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2016.06.028_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.cgt.7700900","article-title":"Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers","volume":"13","author":"Varghese","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2016.06.028_bb0130","first-page":"10","article-title":"CCL21 chemokine therapy for lung cancer","volume":"1","author":"Sharma","year":"2013","journal-title":"Int Trends Immun."},{"key":"10.1016\/j.intimp.2016.06.028_bb0135","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/cancers6021098","article-title":"CCL21 cancer immunotherapy","volume":"6","author":"Yuan","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2016.06.028_bb0140","article-title":"Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.06.028_bb0145","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jgm.623","article-title":"Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses","volume":"6","author":"Kuate","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.intimp.2016.06.028_bb0150","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Gavin","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0155","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.172.4.2643","article-title":"TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens","volume":"172","author":"Zimmermann","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2016.06.028_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/14653249.2011.649185","article-title":"Cytokine-induced killer cells in the treatment of patients with solid carcinom as: a systematic review and pooled analysis","volume":"14","author":"Ma","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2016.06.028_bb0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.intimp.2010.12.014","article-title":"Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies","volume":"11","author":"Niu","year":"2011","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T12:16:28Z","timestamp":1568117788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916302636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"alternative-id":["S1567576916302636"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.028","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21\/IL15 armed oncolytic adenovirus in TERT-positive tumor cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}